IVF After 40: Real Success Rates & Tips

Let's start with an uncomfortable truth that too many fertility websites either sugarcoat or ignore entirely: after 40, IVF success rates with your own eggs decline significantly. That's the biology, and no amount of positive thinking changes it.

But here's the part those same websites also miss: "lower success rates" does not mean "no success." Thousands of women over 40 have successful IVF pregnancies every year. The question isn't whether it's possible - it clearly is. The question is: what do you need to know, do, and decide to give yourself the best possible chance?

This guide is written for women and couples who want data, not platitudes. Who want realistic expectations paired with actionable strategies. Who deserve to make this decision with complete information.

What Are IVF Success Rates by Age After 40?

These figures represent clinical pregnancy rates per embryo transfer cycle using own eggs, based on aggregated data from the Society for Assisted Reproductive Technology (SART) and European Society of Human Reproduction and Embryology (ESHRE):

• Age 40: 20-25% per cycle
• Age 41: 15-20% per cycle
• Age 42: 10-15% per cycle
• Age 43: 5-10% per cycle
• Age 44+: Under 5% per cycle (with own eggs)

Important context: these are per-cycle rates. Cumulative success over multiple cycles is substantially higher. A woman at 40 who undergoes three IVF cycles has a cumulative live birth probability of approximately 35-45% - a very different picture from the 20-25% single-cycle figure.

Why Does Age Matter So Much?

The decline isn't about overall health or fitness. A 42-year-old marathon runner faces the same age-related fertility decline as a 42-year-old who doesn't exercise. The critical factor is egg quality - specifically, the rate of chromosomal abnormalities (aneuploidy) in eggs.

• At age 30: approximately 30% of eggs are aneuploid
• At age 37: approximately 45% are aneuploid
• At age 40: approximately 60% are aneuploid
• At age 43: approximately 80-85% are aneuploid

Aneuploid embryos either fail to implant, result in early miscarriage, or - rarely - lead to chromosomal conditions. This is why PGT-A genetic screening becomes increasingly valuable after 40, as supported by ASRM guidelines: by identifying the chromosomally normal embryos in your cohort, it eliminates the "wasted" transfer cycles on embryos that were never going to succeed.

How Should You Read a Clinic's Success Rates?

The figures above come from national registries, which is why they are worth taking seriously. A clinic's own figures deserve more scrutiny — not because clinics are dishonest, but because a success rate is a construction, and how it is built changes what it says.

Ask what the denominator is. A rate measured per embryo transfer excludes everyone whose cycle was cancelled or who had no embryo to transfer — which, past forty, is a meaningful group. Per cycle started is the harder and more honest measure. Ask about the numerator too: a clinical pregnancy is not a live birth, and the gap between the two widens with age.

Then ask who is counted. A clinic that declines patients with a poor prognosis will publish better numbers than one accepting them, without being better at treating anyone. And check the age bands: "over forty" as a single bracket blends a wide range of prognoses into one figure that describes almost nobody.

The figure that matters is the one for people with your age, your ovarian reserve, and your diagnosis, at that clinic. Ask for it directly — a team that will not answer straight has told you something useful anyway.

Which Tests Build Your Personal Picture?

Age is a population statistic. Your own prognosis depends on where you sit within your age band — and a handful of tests are what locate you. Knowing what each test does not tell you matters just as much.

• AMH (Anti-Müllerian Hormone): estimates how many eggs remain and predicts how you are likely to respond to stimulation. It says nothing about the quality of those eggs, and a low result on its own is not a verdict.
• Antral follicle count: an ultrasound count that complements AMH. Together they shape your protocol more than either does alone.
• FSH and oestradiol: read together, early in the cycle. These fluctuate, so a single reading is a snapshot rather than a trend.
• Assessment of the uterus and lining: ultrasound and, where indicated, hysteroscopy. The uterus ages differently from the ovaries, and a treatable finding here is far better known before a transfer than after one.
• Your partner's semen analysis: non-negotiable. Male factor does not disappear because the conversation has been about your age.

None of these predicts the outcome of a cycle. What they do is turn a general prognosis into a specific one, and let your specialist build a protocol around your biology rather than around an average.

The Add-Ons You Will Be Offered, and What the Regulator Says

After forty you will be offered extras. Some of them are on this page. You are the patient group most likely to be sold add-ons, because you have the least time and the most reason to want anything that might help - so it is worth knowing what the UK regulator has concluded about each one before you are sitting in a consultation.

The HFEA rates fertility treatment add-ons on a five-point scale, and publishes the reasoning behind each rating on its treatment add-ons pages. Its own summary sits at the top of all of them: for most patients, a routine cycle of proven fertility treatment is effective without using any add-ons.

• PGT-A (embryo chromosome screening) - red for one thing, green for another. The HFEA rates it red for improving the chance of having a baby, because it reduces the number of embryos available for transfer and may lengthen the time to a live birth - and green for reducing the chance of miscarriage. For reducing miscarriage specifically in older women it is rated grey, meaning the evidence is insufficient, which is worth knowing if that is being offered to you as the reason. See our guide to PGT for the detail, including the risk of an embryo being wrongly called abnormal - which matters most when you have few.
• AI embryo selection and time-lapse - rated black. Black means moderate-to-high quality evidence shows the add-on has no effect on the outcome. That applies both to automated analysis and to manual analysis of time-lapse images.
• Endometrial receptivity testing (ERA) - rated red. The reasoning is worth reading: if the test is inaccurate, or the window of implantation varies between cycles, the test may actively reduce your chance of a baby by moving the transfer away from the right day.
• DHEA and other androgen supplementation - rated grey. Grey means the effectiveness cannot be rated because there is insufficient good-quality evidence - and the HFEA rates it grey specifically for older women as well as for patients generally. In the UK, DHEA is treated as a medicine rather than a food supplement and is not legally sold over the counter, so it is a conversation with a doctor rather than a purchase.

None of this means never. It means that if a clinic presents any of these as the thing that will make the difference at your age, ask what evidence they are relying on given the rating, ask what each costs on top of the cycle, and ask whether the cycle would be done differently without it. A clinic that answers those three well is worth more than one with a longer menu.

And the travel point: a clinic in Turkey is not HFEA-licensed, so these ratings are guidance to you rather than a rule binding on the clinic, and there is no HFEA inspection or complaints route behind the treatment. That makes asking the questions yourself more important, not less. Add-ons should appear as separate priced lines in the written quote.

How Can You Improve IVF Success After 40?

You can't change your eggs' chronological age. But you can optimize the environment in which those eggs develop, the technology used to assess them, and the clinical protocols applied to your specific biology.

1. Personalized Ovarian Stimulation

After 40, a one-size-fits-all stimulation protocol often underperforms. A good clinic builds the protocol around your AMH (Anti-Müllerian Hormone) level, antral follicle count, and previous cycle response. For patients with diminished ovarian reserve, modified natural cycle or mini-IVF protocols may yield better quality eggs than aggressive high-dose stimulation.

2. PGT-A Genetic Screening

When 60-85% of your eggs may be aneuploid, knowing which embryos are chromosomally normal before transfer is transformative. PGT-A does not improve the per-egg success rate. It raises the per-transfer rate, because embryos that were going to fail are not transferred in the first place — but that is a selection effect rather than an improvement, and trials have not shown it to increase the cumulative chance of a live birth per egg collection. What it can do is shorten the route to an answer and reduce the number of failed transfers along the way. For women over 40, PGT-A-screened euploid embryos have implantation rates of 50-60% - equivalent to much younger patients.

3. AI-Assisted Embryo Selection

Clinics sometimes offer AI time-lapse analysis alongside PGT-A as a further layer of selection. Before agreeing, note that this stacks two chargeable add-ons the HFEA rates black and red respectively - more information about your embryos, without evidence that it produces more babies.

4. Supplements and Lifestyle Optimization

Evidence-based interventions that may support egg quality include:

• CoQ10 (Ubiquinol): widely taken on the reasoning that egg cell division is energy-intensive and CoQ10 supports mitochondrial function. Human evidence for better IVF outcomes is limited rather than established. It is inexpensive, generally well tolerated and freely available - agree the dose and timing with your clinic rather than from an article.
• DHEA: sometimes prescribed for diminished ovarian reserve, but the HFEA rates androgen supplementation grey - it cannot rate the effectiveness because the evidence is insufficient, including specifically for older women. In the UK it is a medicine rather than a supplement and is not legally sold over the counter. We are not going to publish a dose; if your specialist raises it, ask what they expect it to do and how they will monitor you.
• Vitamin D: Optimal levels (40-60 ng/mL) are associated with better IVF outcomes according to Mayo Clinic.
• Mediterranean diet pattern: Rich in omega-3 fatty acids, antioxidants, and whole grains. Multiple studies associate this dietary pattern with improved egg quality and IVF success.
• Stress reduction: Chronic stress elevates cortisol, which can impair follicular development. Mindfulness, acupuncture, and psychological support have shown modest but meaningful benefits.

5. Embryo Banking

For patients over 40 with low egg retrieval numbers per cycle, embryo banking - performing multiple retrieval cycles and accumulating embryos before testing and transferring - can build a larger pool of embryos to screen, increasing the probability of finding at least one chromosomally normal embryo.

Questions to Ask Your Fertility Specialist

A consultation after forty carries more weight than most, because the decisions that follow it are time-sensitive. Take these in writing, and write the answers down.

• Given my AMH, antral follicle count, and history, what would you realistically expect from a cycle?
• Which protocol are you proposing for me, and why that one rather than another?
• Would you expect enough embryos to make PGT-A worthwhile in my case?
• How many cycles would you suggest before we reconsider the whole approach?
• What are your outcomes for patients with my profile, and where are they published?
• If you were in my position, what would you do — and what would you not do?

What to Look For in a Clinic

These are the things worth checking before you choose where to be treated after forty:

• A laboratory that will talk to you about its own results - culture conditions, embryologist experience and the clinic's live birth rate per cycle started in your age band, rather than a list of add-ons it can sell you
• Individualized protocols: Stimulation plans tailored to diminished ovarian reserve, not adapted from younger-patient templates
• Comprehensive support: Fertility psychologists, nutritionists, and dedicated patient coordinators
• Transparent pricing: IVF packages with clear cost breakdowns set out in the written quote issued by the partner hospital

Time does matter here, and it would be dishonest to pretend otherwise: ovarian reserve declines month by month after 40, and that is a fact rather than a sales line. It is also not a reason to decide anything quickly. What a consultation gives you is information - your AMH, your AFC, a realistic prognosis - to make an informed, empowered decision on your own timeline.